T. Rowe Price Associates, Inc. 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 175,776 0.500% |
-3,237,776 (-94.85%) |
Filing |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,413,552 9.900% |
-142,910 (-4.02%) |
Filing |
| 2023-06-12 2:10 pm Purchase |
2023-05-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,556,462 10.400% |
191,575 (+5.69%) |
Filing |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,364,887 9.900% |
-582,798 (-14.76%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,947,685 13.300% |
1,362,201 (+52.69%) |
Filing |
| 2021-02-16 12:24 pm Sale |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 2,585,484 10.500% |
-42,536 (-1.62%) |
Filing |
| 2020-10-13 11:26 am Purchase |
2020-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 2,628,020 10.700% |
1,444,785 (+122.10%) |
Filing |